Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02333604Recruiting

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Role: lead

NCT03347058Not ApplicableCompleted

Immunotherapy & Me

Role: lead

NCT01295658Completed

Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project

Role: lead

NCT01396174Not ApplicableCompleted

A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors

Role: collaborator

All 4 trials loaded